Drug Trial Radar · NCT06104319
Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH
Last checked: Nov 20, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
61
Actual
Start
Jan 22, 2024
Primary completion
Sep 23, 2025
Study completion Sep 23, 2025
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Oct 27, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to understand how the drug GSK4532990 is processed in the body (pharmacokinetics) and how it works in the liver (pharmacodynamics) as well as to ensure it is safe and well-tolerated. The total study duration for each participant will be approximately 24-36 weeks.
Conditions
- Non-alcoholic Fatty Liver Disease
Interventions
GSK4532990Drug
GSK4532990 will be administered
Primary outcomes
What the sponsor says the trial is designed to measure.
- Predicted Mean Percent Change From Baseline (CFB) in Liver Biopsy-derived HSD17B13 Protein Expression LevelsTime frame: Baseline (Day 1), At weeks 8, 12 and 28
- Predicted Mean Percent Change From Baseline (CFB) in Liver Biopsy-derived HSD17B13 mRNA Expression LevelsTime frame: Baseline (Day 1), At weeks 8, 12 and 28
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
GSK Investigational Site
Chula Vista, California
GSK Investigational Site
Montclair, California
GSK Investigational Site
San Diego, California
GSK Investigational Site
San Diego, California
GSK Investigational Site
Brandon, Florida
GSK Investigational Site
Miami, Florida
GSK Investigational Site
Miami, Florida
GSK Investigational Site
Miami Lakes, Florida
GSK Investigational Site
Indianapolis, Indiana
GSK Investigational Site
El Dorado, Kansas
GSK Investigational Site
Marrero, Louisiana
GSK Investigational Site
Austin, Texas
GSK Investigational Site
San Antonio, Texas
GSK Investigational Site
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.